West Pharmaceutical Services, Inc.
US ˙ NYSE ˙ US9553061055

SecurityWST / West Pharmaceutical Services, Inc.
InstitutionWELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2
Latest Disclosed Ownership56 shares
Latest Disclosed Value $ 12,252
WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 reports 6.67% decrease in ownership of WST / West Pharmaceutical Services, Inc.

On August 26, 2025 - WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 filed a NPORT-P form disclosing ownership of 56 shares of West Pharmaceutical Services, Inc. (US:WST) valued at $12,253 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 60 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of -6.67% during the quarter. The current value of the position is $17,612 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP West Pharmaceutical Services EC US9553061055 56 -4 -6.67 12 -7.69 0.0181
2025-05-27 2025-03-31 NP West Pharmaceutical Services EC US9553061055 60 -1 -1.64 13 -31.58 0.0202
2025-02-26 2024-12-31 NP West Pharmaceutical Services EC US9553061055 61 -5 -7.58 20 0.00 0.0286
2024-11-25 2024-09-30 NP West Pharmaceutical Services EC US9553061055 66 -2 -2.94 20 -13.64 0.0273
2024-08-26 2024-06-30 NP West Pharmaceutical Services EC US9553061055 68 -2 -2.86 22 -18.52 0.0321
2024-05-28 2024-03-31 NP West Pharmaceutical Services EC US9553061055 70 -4 -5.41 28 3.85 0.0397
2024-02-28 2023-12-31 NP West Pharmaceutical Services EC US9553061055 74 -2 -2.63 26 -7.14 0.0391
2023-11-22 2023-09-30 NP West Pharmaceutical Services EC US9553061055 76 -9 -10.59 29 -12.50 0.0459
2023-08-28 2023-06-30 NP West Pharmaceutical Services EC US9553061055 85 1 1.19 33 10.34 0.0490
2023-05-25 2023-03-31 NP West Pharmaceutical Services EC US9553061055 84 -2 -2.33 29 45.00 0.0451
2023-02-24 2022-12-31 NP West Pharmaceutical Services EC US9553061055 86 -1 -1.15 20 -4.76 0.0324
2022-11-29 2022-09-30 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 87 -3 -3.33 21 -22.22 0.0349
2022-08-29 2022-06-30 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 90 -1 -1.10 27 -27.03 0.0414
2022-05-31 2022-03-31 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 91 -3 -3.19 37 -15.91 0.0489
2022-02-28 2021-12-31 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 94 -3 -3.09 44 7.32 0.0530
2021-11-24 2021-09-30 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 97 -4 -3.96 41 13.89 0.0512
2021-08-27 2021-06-30 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 101 -6 -5.61 36 20.00 0.0442
2021-06-01 2021-03-31 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 107 -6 -5.31 30 -6.25 0.0380
2021-03-01 2020-12-31 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 113 -7 -5.83 32 0.00 0.0406
2020-11-25 2020-09-30 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 120 -4 -3.23 33 14.29 0.0443
2020-08-28 2020-06-30 NP WEST PHARMACEUTICAL SERVICES USD.25 EC US9553061055 124 124 28 0.0396
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.